Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,557 | -11,148 | N/A | -32,801 | -21,653 |
| Depreciation Amortization | 487 | 245 | N/A | 643 | 420 |
| Accounts receivable | -1,406 | -1,406 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,906 | 606 | N/A | -540 | -202 |
| Other Working Capital | -3,582 | -5,576 | N/A | 2,458 | 355 |
| Other Operating Activity | 2,109 | 2,075 | 0 | 4,448 | 2,817 |
| Operating Cash Flow | $-22,043 | $-15,204 | $N/A | $-25,792 | $-18,263 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 24,614 | 13,595 |
| PPE Investments | -46 | -40 | N/A | -171 | -77 |
| Investing Cash Flow | $-46 | $-40 | $N/A | $24,443 | $13,518 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 165 | 155 | N/A | 185 | 39 |
| Financing Cash Flow | $165 | $155 | $N/A | $185 | $39 |
| Beginning Cash Position | 54,640 | 54,640 | N/A | 64,731 | 64,731 |
| End Cash Position | 32,716 | 39,551 | N/A | 63,567 | 60,025 |
| Net Cash Flow | $-21,924 | $-15,089 | $N/A | $-1,164 | $-4,706 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,043 | -15,204 | N/A | -25,792 | -18,263 |
| Capital Expenditure | -46 | -40 | N/A | -171 | -77 |
| Free Cash Flow | -22,089 | -15,244 | 0 | -25,963 | -18,340 |